StartUPDATES: New developments from healthcare startups
Check out new developments from Seven Bridges, Healthmine, Bright Health, and My One Medical Source.
StartUPDATES: New developments for healthcare startups
Read about news from Seven Bridges, HealthMine, Redi.Health, Xealth, and more.
Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
StartUPDATES: New developments from healthcare startups
Check out new developments from HealthMine, Seven Bridges, Lemonaid Health, and more.
StartUPDATES: New developments from healthcare startups
Read about new developments from Vivor, Kiio, Blue Therapeutics, and Seven Bridges.
StartUPDATES: New developments from healthcare startups
Read about new developments from Seven Bridges, Blue Therapeutics, Outcomes4Me and more.
StartUPDATES: New developments from healthcare startups
Read new developments on healthcare startups such as Seven Bridges, Scipher Medicine, Applied VR and more.
Consultants: Help Define What’s Next In Healthcare Benefits
Help shape the future of healthcare benefits by sharing your insights.
StartUPDATES: New developments from healthcare startups
This week, read new developments at Carrum Health, Seven Bridges, CARISMA Therapeutics, and more.
StartUPDATES: New developments for healthcare startups
Read about news from Seven Bridges, Outcomes4Me, Carrum Health and more.
StartUPDATES: New developments from healthcare startups
Check out news from healthcare startups including Carrum Health, Seven Bridges Genomics, Outcomes4Me and more.
StartUPDATES: New developments for healthcare startups
Check out news from healthcare startups including Truvian Sciences and Seven Bridges Genomics.
Tackling Rising Drug Costs and Growing Popularity of GLP-1’s
See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.
Founders’ story: Seven Bridges
A Q&A with executives from Seven Bridges, a bioinformatics analysis business, highlights the company's work in the precision medicine sector.